Latest peer-reviewed research: Immediate global ivermectin use will end COVID-19 pandemic
A focus of the manuscript was on the 27 controlled trials available in January 2021, 15 of which were randomized controlled trials (RCT’s), the preferred trial of the World Health Organization, U.S. National Institutes of Health, and the European Medicines Agency. Consistent with numerous meta-analyses of ivermectin RCT’s since published by expert panels from the UK, Italy, Spain, and Japan, they found large, statistically significant reduction in mortality, time to recovery and viral clearance in COVID-19 patients treated with ivermectin.
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
#longcovid #transmission #emerging
data analysis, python programming, ivermectin, efficacy, transmission, meta-analyses, controlled trials, Prophylaxis, data science, bioinformatics, vaccine, BNT162b2, sars-cov-2
#data analysis, #python programming,# ivermectin, #efficacy, #transmission, #meta-analyses, #controlled trials, #data science, #bioinformatics